Apotex Expands US Presence with Modafinil Acquisitions
Deal News | Jan 09, 2025 | SK Capital
Apotex Inc., Canada's largest pharmaceutical company, has announced the acquisition of US rights to the drugs PROVIGIL and NUVIGIL through its affiliate, Nuvo Pharmaceuticals (Ireland). These drugs are known for treating excessive sleepiness associated with conditions such as narcolepsy and obstructive sleep apnea. This acquisition marks an important strategic expansion for Apotex into the US specialty pharmaceutical market, aligning with their broader growth strategy aimed at improving patient care and increasing their footprint in the US market. Allan Oberman, CEO of Apotex, emphasized the importance of this acquisition in enhancing their specialty offerings in the US and continuing their growth momentum, capitalizing on their commercial expertise and established distribution networks.
Sectors
- Pharmaceuticals
- Healthcare
Geography
- United States – Apotex's acquisition deals with US rights to the drugs PROVIGIL and NUVIGIL, highlighting the US market as the geographic focus.
- Canada – Apotex is the largest Canadian-based pharmaceutical company, with the headquarters in Toronto, Canada, showing the company's origin.
Industry
- Pharmaceuticals – The article revolves around Apotex's acquisition of rights to drugs that are part of the pharmaceuticals industry, specifically addressing sleep disorders.
- Healthcare – Apotex's acquisition of rights to pharmaceutical products aimed at improving patient care positions this article within the broader healthcare industry.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Apotex Inc. | Acquiring Company | Company | Apotex Inc. is Canada's largest pharmaceutical company, acquiring US rights to PROVIGIL and NUVIGIL. |
| Nuvo Pharmaceuticals (Ireland) DAC | Affiliated Company | Company | Apotex's affiliate responsible for the acquisition of US rights to the drugs. |
| SK Capital | PE Firm | PE Firm | Involved as the Private Equity company that facilitated the acquisition process. |
| Allan Oberman | President & CEO | Person | Allan Oberman is the President & CEO of Apotex who commented on the strategic significance of the acquisition. |
| Christine Baeder | President of Apotex Corp. | Person | President of Apotex's US affiliate, emphasized the execution and market expertise of Apotex in the US. |